SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-000826
Accepted
2024-04-03 00:15:23
Documents
1
Effectiveness Date
2024-04-02
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-24-000826.txt   1775
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-273384 | Film No.: 24816753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)